Australia Markets close in 1 hr 43 mins

Anagenics Limited (AN1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.02600.0000 (0.00%)
As of 10:32AM AEDT. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.76
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.0510
52-week low 30.0190
50-day moving average 30.0235
200-day moving average 30.0292

Share statistics

Avg vol (3-month) 379.13k
Avg vol (10-day) 3129.5k
Shares outstanding 5221.27M
Implied shares outstanding 6N/A
Float 8113.05M
% held by insiders 148.85%
% held by institutions 12.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022

Profitability

Profit margin -39.51%
Operating margin (ttm)-37.03%

Management effectiveness

Return on assets (ttm)-16.30%
Return on equity (ttm)-38.97%

Income statement

Revenue (ttm)9.23M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)5.07M
EBITDA -3.33M
Net income avi to common (ttm)-3.65M
Diluted EPS (ttm)-0.0240
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.28M
Total cash per share (mrq)0.01
Total debt (mrq)1.76M
Total debt/equity (mrq)21.20
Current ratio (mrq)2.40
Book value per share (mrq)0.06

Cash flow statement

Operating cash flow (ttm)-2.53M
Levered free cash flow (ttm)-993.24k